Biohacker Bryan Johnson's Unconventional Experiment: Menstrual Blood in the Freezer

In a world where biohacking is becoming increasingly mainstream, tech entrepreneur Bryan Johnson has taken his obsession with health and longevity to a new level. The 48-year-old founder of Kernel and Braintree is not just focused on reversing his biological age; he is also collecting his girlfriend's menstrual blood, which he has stored in a -80 °C freezer. This peculiar practice raises significant ethical questions about the intersection of biotechnology and personal health, making it a topic of interest for conspiracy researchers and bioethics advocates alike.

The Quest for Immortality

Johnson's journey into extreme biohacking is driven by a desire to become the healthiest person on the planet. He meticulously tracks his health metrics, adheres to a strict diet, and consumes a plethora of supplements daily. His self-proclaimed title as the “most biologically measured person ever” reflects his commitment to this lifestyle. However, his latest venture—storing menstrual blood—has sparked a mix of intrigue and skepticism.

The biohacker's announcement on social media, where he shared a photo of his girlfriend, Kate Tolo, alongside her menstrual blood, has raised eyebrows. Johnson claims that menstrual blood is a valuable resource for understanding women's health, describing it as a “non-invasive look into the uterus.” This assertion opens the door to discussions about the underutilization of female biological data in medical research, a point that resonates with many advocates for women's health.

Ethical Implications of Biohacking

While Johnson's intentions may be rooted in scientific curiosity, the ethical implications of his actions cannot be overlooked. The concept of using a partner's bodily fluids for experimentation raises questions about consent, privacy, and the commercialization of personal health data. Tolo, who has publicly supported Johnson's endeavors, is reportedly collecting extensive data on her menstrual cycle, which includes over 14 million data points monitored by a team of medical professionals. However, the extent of her involvement and the potential risks associated with such data collection remain unclear.

Lead image — via The Guardian

• **Key Concerns:
  • Consent and autonomy in personal health experiments.
  • The commercialization of women's health data.
  • The potential for exploitation in biohacking practices.**

The Marketing Angle

Johnson and Tolo's initiative is not without its critics. Their company, Immortals, which focuses on health supplements, is reportedly on the verge of launching products aimed at women. This raises suspicions that their biohacking efforts may serve as a marketing strategy rather than a genuine scientific pursuit. The timing of their menstrual blood research coinciding with product launches could be seen as a calculated move to capitalize on the growing interest in women's health.

In a society where women's health has historically been marginalized, Johnson's project could be viewed as a double-edged sword. While it aims to destigmatize menstruation and promote awareness, it also risks commodifying women's bodies and experiences for profit. This tension between empowerment and exploitation is a critical aspect for conspiracy researchers to consider as they analyze the implications of such biohacking practices.

The Future of Women's Health Research

Johnson's approach to women's health research highlights a significant gap in the medical field: the lack of comprehensive studies focused on menstruation and female biology. Until recently, many clinical trials excluded women or used saline solutions instead of human blood for testing menstrual products. This historical oversight has led to a lack of understanding and inadequate care for women's health issues.

As Johnson and Tolo embark on their ambitious project, they may inadvertently contribute to a broader conversation about the need for more inclusive research practices. However, the question remains: will their efforts lead to meaningful advancements in women's health, or will they merely serve as a spectacle in the world of biohacking?

As we reflect on Johnson's unconventional methods, we must ask ourselves:

• What are the ethical boundaries of biohacking in personal health?
• How can we ensure that women's health research is conducted responsibly and ethically?